New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
07:43 EDTAMRNAmarin receives two new patent allowances related to Vascepa
Amarin announced that the United States Patent and Trademark Office, or USPTO, has published notification of Notices of Allowance for Amarin's U.S. Patent Applications Serial Numbers 13/458,496 and 13/349,157. The allowed '496 and '157 applications continue to broaden our claimed methods of reducing triglycerides consistent with the FDA approved MARINE indication for Vascepa capsules through use of a pharmaceutical composition of highly pure icosapent ethyl, or EPA. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. The issued patents would have terms that expire no earlier than in 2030. After issuance, Amarin plans to list these patents in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.
News For AMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
11:36 EDTAMRNAmarin management to meet with SunTrust
Subscribe for More Information
March 20, 2015
05:51 EDTAMRNStocks with implied volatility movement; AMRN EWG
Stocks with implied volatility movement; Amarin (AMRN) 140, iShares MSCI Germany (EWG) 20 according to iVolatility.
March 17, 2015
08:54 EDTAMRNAmarin says study suggest EPA pretreatment reduces oxidative damage
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use